Showing results (681-690 of 692) with videos related to

Sort By:
Pageof 70
Hepatology (Baltimore, Md.)|May 6, 2026
Exploring the interaction between metabolic dysfunction and alcohol-associated hepatitis: A global studyVania Cari, María Ignacia Perez, Ignacio Tellez, et al.
Hepatology (Baltimore, Md.)|June 26, 2023
A multisociety Delphi consensus statement on new fatty liver disease nomenclatureMary E Rinella, Jeffrey V Lazarus, Vlad Ratziu, et al.
Annals of Hepatology|June 26, 2023
A multisociety Delphi consensus statement on new fatty liver disease nomenclatureMary E Rinella, Jeffrey V Lazarus, Vlad Ratziu, et al.
Journal of Hepatology|June 26, 2023
A multisociety Delphi consensus statement on new fatty liver disease nomenclatureMary E Rinella, Jeffrey V Lazarus, Vlad Ratziu, et al.
JHEP Reports : Innovation in Hepatology|February 21, 2025
Global burden of metabolic dysfunction-associated steatotic liver disease, 2010 to 2021Gong Feng, Giovanni Targher, Christopher D Byrne, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 27, 2025
Longitudinal Changes in Fibrosis Markers: Monitoring Stiffness/Fibrosis Progression and Prognostic Outcomes in MASLDXiao-Dong Zhou, Yu-Ting Li, Seung Up Kim, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|October 3, 2024
acFibroMASH Index for the Diagnosis of Fibrotic MASH and Prediction of Liver-related Events: An International Multicenter StudyGong Feng, Ferenc E Mózes, Dong Ji, et al.
Med (New York, N.Y.)|December 23, 2025
Fibrotic MASH resolutionVCTE index to diagnose fibrotic MASH resolution and predict LREs: A global multicenter studyGong Feng, Jérôme Boursier, Marc de Saint Loup, et al.
The American Journal of Gastroenterology|July 17, 2026
Characteristics and outcomes of patients with imaging-defined MASLD and histological steatosis grade S0Wen-Yue Liu, Li-You Lian, Seung Up Kim, et al.
Pageof 70